Cargando…

Use of methylphenidate in the treatment of major depressive disorder in an outpatient mental health center

Detalles Bibliográficos
Autores principales:	Lacueva, Carolina Garnier, Castaño, Juan, Alvaro, Patricia, Sanchis, Rosa, Córcoles, David, Portillo, Francisco, Diaz, Belen, Martin, Luis Miguel, Bulbena, Antoni
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991855/ http://dx.doi.org/10.1186/1744-859X-9-S1-S167

Ejemplares similares

Use of benzodiazpines in the treatment of major depressive disorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

Use of mood stabilizer drugs in the treatment of major depressive dissorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

Use of antipsychotics in the treatment of major depressive disorder in an outpatient mental health center
por: Garnier, Carolina, et al.
Publicado: (2010)

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients
por: Martín-López, Luis M., et al.
Publicado: (2011)

Use of Methylphenidate in Coexisting Major Depression, Loss of Libido and Erectile Dysfunction
por: Nazlı, Şerif Bora, et al.
Publicado: (2021)

Temperament and major depressive disorder
por: Karam, Elie G, et al.
Publicado: (2010)

A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch
por: Patel, Kamal, et al.
Publicado: (2019)

Effectiveness of Short‐Term Dynamic Group Psychotherapy in Primary Care for Patients with Depressive Symptoms
por: Bros, Ignasi, et al.
Publicado: (2016)

The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder
por: Aryan, Nazanin, et al.
Publicado: (2020)

Sensitivity and specificity of the Major Depression Inventory in outpatients
por: Cuijpers, Pim, et al.
Publicado: (2007)

Rare giant malignant tumors of the chest - reconstructive challenge
por: Kurowski, K, et al.
Publicado: (2015)

Síntomas neuropsiquiátricos como factor de confusión en la detección de la demencia
por: Córcoles, David, et al.
Publicado: (2018)

Profile of patients seen at food allergy outpatient unit in the municipality of taubaté
por: Da Matta Ain, Ana Carolina, et al.
Publicado: (2015)

Asthma features in elderly in a terciary outpatients facility
por: De Castro, Nathalia Siqueira Robert, et al.
Publicado: (2015)

The American Psychiatric Association Treatment Guideline for Major Depressive Disorder: process and content
por: Gelenberg, Alan J
Publicado: (2010)

Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury
por: Zhang, Wei-Tao, et al.
Publicado: (2017)

Availability of outpatient methadone maintenance
por: Creedon, Timothy B, et al.
Publicado: (2015)

Oral food challenges in a specialized allergy outpatient clinic in São Paulo, Brazil
por: Rozalem, Ana Carolina, et al.
Publicado: (2015)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Unintentional Injuries among Psychiatric Outpatients with Major Depressive Disorder
por: Hung, Ching-I, et al.
Publicado: (2016)

Methylphenidate-associated myopathy
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

The cardiovascular safety of methylphenidate
por: Jackson, John W
Publicado: (2016)

Editorial: Attention and Methylphenidate
por: Avital, Avi, et al.
Publicado: (2020)

Endophenotypic markers of bipolar disorder (BD) in probands and their first degree relatives with major depression (MD)
por: Christodoulou, Anastasia Tessa
Publicado: (2010)

Pharmacoepidemiological aspects of outpatient pain medication
por: Zebedin, Eva-Maria, et al.
Publicado: (2011)

Family Features of Social Withdrawal Syndrome (Hikikomori)
por: Malagón-Amor, Ángeles, et al.
Publicado: (2020)

Major depression and generalized anxiety disorder among HTLV-I/II infected former blood donors
por: Guiltinan, Anne M, et al.
Publicado: (2011)

An association study between various monoamine transporter gene polymorphisms and treatment response to mirtazapine in major depression
por: Choi, Hong
Publicado: (2010)

High reward expectancy during methylphenidate depresses the dopaminergic response to gain and loss
por: Evers, E.A., et al.
Publicado: (2016)

Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study
por: Ramasubbu, Rajamannar, et al.
Publicado: (2008)

The potency of psychiatric questionnaires to distinguish major mental disorders in Chinese outpatients
por: Wang, Jiayi, et al.
Publicado: (2022)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Excess cost of non-remission among outpatients with major depressive disorder
por: Woo, Jong-Min, et al.
Publicado: (2014)

Association of periodontal health indicators and major depressive disorder in hospital outpatients
por: Kumar, Amit, et al.
Publicado: (2015)

Reproductive toxicology. Methylphenidate hydrochloride.
Publicado: (1997)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

Retrospective assessment of inguinal hernia repair in elderly outpatients
por: Palumbo, P, et al.
Publicado: (2010)

Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response
por: da Silva, Bruna S., et al.
Publicado: (2019)

Role of Peripheral Vascular Resistance for the Association Between Major Depression and Cardiovascular Disease
por: Bouzinova, Elena V., et al.
Publicado: (2015)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cuegdr631aetjr135m3lhge21d